<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E9486EB9-D3D0-42B0-B16C-03D624CE3B22"><gtr:id>E9486EB9-D3D0-42B0-B16C-03D624CE3B22</gtr:id><gtr:name>Genus plc</gtr:name><gtr:address><gtr:line1>Belvedere House</gtr:line1><gtr:line2>Basing View</gtr:line2><gtr:line4>Basingstoke</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>RG21 4HG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Veterinary Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E9486EB9-D3D0-42B0-B16C-03D624CE3B22"><gtr:id>E9486EB9-D3D0-42B0-B16C-03D624CE3B22</gtr:id><gtr:name>Genus plc</gtr:name><gtr:address><gtr:line1>Belvedere House</gtr:line1><gtr:line2>Basing View</gtr:line2><gtr:line4>Basingstoke</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>RG21 4HG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BCA8A0AB-5B3A-4CF6-A412-D5BF12641AD6"><gtr:id>BCA8A0AB-5B3A-4CF6-A412-D5BF12641AD6</gtr:id><gtr:firstName>Laurence</gtr:firstName><gtr:otherNames>Stephen</gtr:otherNames><gtr:surname>Tiley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FM018385%2F1"><gtr:id>341836EB-43C4-40CC-87BA-78019C44B80C</gtr:id><gtr:title>14-ATC2. Engineering resistance to disease in pigs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/M018385/1</gtr:grantReference><gtr:abstractText>This project addresses food security and environmental sustainability by increasing production efficiency by reducing wastage due to disease and thus decreasing the carbon footprint of pork production. We will target the significant impact of influenza virus on one of our core livestock industries. Swine influenza (SIV) ranks consistently among the top 3 economic diseases affecting breeding, nursery, and finishing herds. In addition, influenza is the top zoonotic viral disease of swine. Our strategy is based on the recent validation of a novel RNA decoy approach in chickens. We now aim to use this newly developed technology to produce genetically engineered (GE) pigs expressing novel RNA molecules designed to prevent replication and propagation of SIV. We aim to mitigate or even eliminate mortality and morbidity due to SIV infection in pigs, while additionally protecting human health by reducing the zoonotic flu pandemic potential. It is the intention that this project will function as a 'prototype' study and, if successful, with further method refinement lead to development of a commercial product.</gtr:abstractText><gtr:technicalSummary>This project addresses food security and environmental sustainability by increasing production efficiency by reducing wastage due to disease and thus decreasing the carbon footprint of pork production. We will target the significant impact of influenza virus on one of our core livestock industries. Swine influenza (SIV) ranks consistently among the top 3 economic diseases affecting breeding, nursery, and finishing herds. In addition, influenza is the top zoonotic viral disease of swine. Our strategy is based on the recent validation of a novel RNA decoy approach in chickens. We now aim to use this newly developed technology to produce genetically engineered (GE) pigs expressing novel RNA molecules designed to prevent replication and propagation of SIV. We aim to mitigate or even eliminate mortality and morbidity due to SIV infection in pigs, while additionally protecting human health by reducing the zoonotic flu pandemic potential. It is the intention that this project will function as a 'prototype' study and, if successful, with further method refinement lead to development of a commercial product.</gtr:technicalSummary><gtr:potentialImpactText>Who will benefit from this research?

The non-academic beneficiaries of this research include pig breeding companies, pig producers and ultimately the entire chain of users of pig products, including meat packers, processors, retailers and consumers. There are also benefits to the animal biotechnology sector.


How will they benefit from this research?

Influenza is a high profile zoonotic disease of man, livestock and wild animals. Vaccines are limited to virus strains and cannot be applied to wild animal populations. Single pandemics caused by the virus can be associated with huge numbers of human deaths in addition to vast hospital care costs. Thus, the development of novel and/or more effective strategies to control influenza are needed to limit the annual and pandemic associated human death rates, reduce burden on the health industry, while improving the sustainability of the pig industry and potentially reduce the cost of pig products.

In the pig breeding sector the research outputs will have the potential to inform future breeding programmes. The pig breeding industry has already incorporated selection for desirable disease resistance genes into breeding programmes. To date selection for disease resistance has been limited to diseases for which susceptibility is determined by a single major gene. Moreover, breeding for disease resistance is constrained by the nature of any genetic variation in susceptibility to infection. Whilst evidence for genetic variation in host responses to infection with influenza exists, the genetic control of these responses is polygenic and there is no evidence to date of major genes conferring complete resistance to influenza. With increasing capabilities to genetically modify farmed animals there are opportunities to engineer resistance. It is now timely to explore the opportunities for engineering pigs for enhanced resilience infection. The interaction between host (pig) and pathogen (influenza) are now better understood and new genome editing technologies facilitate the necessary engineering.

Public acceptance of genetically modified animals remains uncertain, especially in Europe. However, the development of non-transgenic pigs engineered for enhanced disease resistance using genome editing technology, which introduces no exogenous DNA, has the potential to re-shape the debate. Moreover, given the impact of influenza in farm animals and man, beneficial impacts could be delivered to the pig industry within 3-5 years of project completion.</gtr:potentialImpactText><gtr:fund><gtr:end>2016-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>122795</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>BW</gtr:description><gtr:id>9E286521-CCD2-4C59-ACE5-56CAC68DFEBD</gtr:id><gtr:impact>Research funding from the TSB Catalyst scheme</gtr:impact><gtr:partnerContribution>Gene editing and TALEN-based technology for introducing transgenes into swine germ line.</gtr:partnerContribution><gtr:piContribution>Conception design and construction of transgenes intended to suppress influenza virus replication in pigs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genus plc</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genus</gtr:description><gtr:id>933CD60D-AD8B-41C9-B9D2-D4198F603061</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>6 months financial support for postdoctoral researcher. University fees for a Ph.D student.</gtr:partnerContribution><gtr:piContribution>Design of porcine ribozyme elements for processing short hairpin inhibitory RNA molecules. Provision of lentiviral vectors caring influenza virus inhibitory transgenes. Construction of shRNA expression system that does not stimulate RIG-I signalling pathway in porcine cells (ongoing project)</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interview by National Geographic journalist</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>345E5109-B053-4852-8A68-215D24359BDF</gtr:id><gtr:impact>Telephone interview and subsequent written correspondence and provision of materials. Journalist writes for &amp;quot;The Plate&amp;quot; articles in National Geographic. Provided a balanced but generally pro-GM report on the potential of transgenic disease resistant animals.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://theplate.nationalgeographic.com/2015/08/05/want-a-bird-flu-free-world-consider-breeding-resistant-birds/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for the  magazine Science &amp; Vie (Science &amp; Life, the n?1 science magazine in France)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8B4FF87A-DCCD-45DD-B6CC-320347998815</gtr:id><gtr:impact>Interview for an article on genetically modified farm animals resistant to infectious diseases.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>36000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Studentship funding</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Genus plc</gtr:fundingOrg><gtr:id>D0E54B45-0070-4C5C-BB26-DB1B0B5A3B78</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have identified a way to express inhibitory RNAs in swine cells that avoid activating the innate immune response of transgenic pigs. Transgenic pigs were generated using this system and tested to determine whether infected transgenic pigs had reduced capacity for transmitting the virus onto contact non-transgenic pigs. The &amp;quot;RNA decoy&amp;quot; transgene used did not significantly change the susceptibility to infection or influence the transmission dynamics.</gtr:description><gtr:exploitationPathways>Expression of short hairpin RNAs that do not activate RIG-I signalling pathways. Production of disease resistant pigs.</gtr:exploitationPathways><gtr:id>67750D59-25A2-4D96-A11B-2728F9DE7DC8</gtr:id><gtr:sectors><gtr:sector>Agriculture, Food and Drink</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Lentiviral vetor system used to deliver short hairpin RNA genes into pig genome with the intention of suppressing influenza virus replication.</gtr:description><gtr:id>311D8A6B-AA88-448B-A361-4A800C6360DA</gtr:id><gtr:impact>No impact yet. Pigs are being bred to permit in vivo challenge experiments to test efficacy.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Transgenic pigs carrying inhibitory transgene targeting  influenza virus</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A method for expressing short structured RNAs that are then processed by endogenous enzymes to remove immunostimulatory 5'PPP moiety.</gtr:description><gtr:id>2FFD9CDC-6913-426C-95A7-FF8588A6657E</gtr:id><gtr:impact>Allows constitutive expression of silencing/decoy RNAs in species with a functional RIG-I pathway.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Method for expressing short interfering RNAs in vivo without activating RIG-I innate immune response</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29A73804-1445-45F5-BB56-628161F8C3D8"><gtr:id>29A73804-1445-45F5-BB56-628161F8C3D8</gtr:id><gtr:title>Adaptation of avian influenza virus to a swine host.</gtr:title><gtr:parentPublicationTitle>Virus evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c0764f238bb103b77a7d5d968ebf54d"><gtr:id>8c0764f238bb103b77a7d5d968ebf54d</gtr:id><gtr:otherNames>Bourret V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2057-1577</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/M018385/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>C23BE70F-1EF6-4CC7-88B0-841CB18DD875</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Genetics &amp; development</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>A502D25A-BB70-4F74-844D-32A2BAD075A5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Diseases</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>4A2A69ED-37ED-4980-91A7-E54B4F6A9BC6</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal organisms</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>273D0117-A926-4A3C-B5B4-070030DD22D9</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Gene therapy</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E2AC43A0-F15F-4F00-8557-FB2D01D65940</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Immunology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>B76F0E6B-0363-4D1F-9F5F-353AFD4E9DB0</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Livestock production</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>